My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Neupogen Singleject 48 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim



Amgen Europe B.V.PA1026/001/008

Main Information

Trade NameNeupogen Singleject 48 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim
Active SubstancesFilgrastim
Dosage FormSolution for injection in pre-filled syringe
Licence HolderAmgen Europe B.V.
Licence NumberPA1026/001/008

Group Information

ATC CodeL03AA Colony stimulating factors
L03AA02 filgrastim

Status

License statusAuthorised
Licence Issued16/11/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
FAO: Healthcare ProfessionalsThe HPRA has become aware of an issue on our website relating to the transfer of the microgram symbol – µg – into past pdf and html versions of the SPC for this Neupogen medicine. The information is correct in the current SPC linked above. If you previously printed or saved the pdf of the SPC for this medicine, we recommend you replace it with the most up-to-date version. You should also refresh the cache of your internet browser (based on instructions for the browser you are using).
« Back
Follow medicine

Print